Search hospitals > Rhode Island > Providence
Women and Infants Hospital
Claim this profileProvidence, Rhode Island 02905
Global Leader in Ovarian Cancer
Global Leader in Fallopian Tube Cancer
Conducts research for Breast Cancer
Conducts research for Peritoneal Carcinoma
Conducts research for Endometrial Cancer
349 reported clinical trials
24 medical researchers
Summary
Women and Infants Hospital is a medical facility located in Providence, Rhode Island. This center is recognized for care of Ovarian Cancer, Fallopian Tube Cancer, Breast Cancer, Peritoneal Carcinoma, Endometrial Cancer and other specialties. Women and Infants Hospital is involved with conducting 349 clinical trials across 394 conditions. There are 24 research doctors associated with this hospital, such as Cara Mathews, MD, Katina M. Robison, William M. Sikov, and Abbot R Laptook, MD.Area of expertise
1Ovarian Cancer
Global LeaderStage IV
Stage III
BRCA1 positive
2Fallopian Tube Cancer
Global LeaderStage IV
Stage III
BRCA2 positive
Top PIs
Cara Mathews, MDWomen and Infants Hospital2 years of reported clinical research
Studies Ovarian Cancer
Studies Endometrial Adenocarcinoma
22 reported clinical trials
44 drugs studied
Katina M. RobisonWomen and Infants Hospital7 years of reported clinical research
Studies Ovarian Cancer
Studies Cancer
14 reported clinical trials
29 drugs studied
William M. SikovWomen and Infants Hospital2 years of reported clinical research
Expert in Breast Cancer
Studies Breast cancer
14 reported clinical trials
33 drugs studied
Abbot R Laptook, MDBrown University - Women and Infants Hospital of Rhode Island5 years of reported clinical research
Studies Premature Birth
Studies Premature Infants
9 reported clinical trials
14 drugs studied
Clinical Trials running at Women and Infants Hospital
Ovarian Cancer
Breast Cancer
Endometrial Cancer
Uterine Cancer
Breast cancer
Cervical Cancer
Cancer
Endometrial Adenocarcinoma
Fallopian Tube Cancer
Solid Tumors
Olaparib +/- Bevacizumab
for Ovarian Cancer
This phase III trial compares the effect of olaparib for one year versus two years, with or without bevacizumab, for the treatment of BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer. Olaparib is a polyadenosine 5'-diphosphoribose polymerase (PARP) enzyme inhibitor and may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving olaparib for one year with or without bevacizumab may be effective in treating patients with BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer, when compared to two years of olaparib.
Recruiting2 awards Phase 34 criteria
Sacituzumab Tirumotecan
for Ovarian Cancer
The main goals of this study are to learn about the safety of sacituzumab tirumotecan with bevacizumab and if people tolerate it; and If people who take sacituzumab tirumotecan with or without bevacizumab live longer without the cancer getting worse than those who receive standard of care treatment.
Recruiting2 awards Phase 35 criteria
LY4170156
for Ovarian Cancer
This is a clinical study that has two parts. It is testing a potential new medicine called LY4170156 for people with certain types of ovarian, peritoneal, and fallopian tube cancers. Part A looks at participants whose cancer no longer responds to platinum-based treatments (a type of chemotherapy). Part B looks at participants whose cancer still responds to platinum-based treatments. The researchers want to find out if LY4170156 works better than the usual treatments that doctors use now and to better understand how safe it is. Each participant's time in the study will depend on how they respond to the treatment.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Women and Infants Hospital?
Women and Infants Hospital is a medical facility located in Providence, Rhode Island. This center is recognized for care of Ovarian Cancer, Fallopian Tube Cancer, Breast Cancer, Peritoneal Carcinoma, Endometrial Cancer and other specialties. Women and Infants Hospital is involved with conducting 349 clinical trials across 394 conditions. There are 24 research doctors associated with this hospital, such as Cara Mathews, MD, Katina M. Robison, William M. Sikov, and Abbot R Laptook, MD.
Where is Women and Infants Hospital located?
To reach Women and Infants Hospital in Providence, Rhode Island:
1. Take Interstate 95 South to Exit 19, Eddy Street.
2. Bear left towards Eddy Street, then turn right onto Eddy Street at the light.
3. At the first set of lights on Eddy Street, turn right onto Dudley Street. The hospital is approximately 0.2 miles on the right.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance-related inquiries at Women and Infants Hospital, please contact (401) 274-1122 x42120, available Monday through Friday, 9 a.m. to 5 p.m. If you're facing difficulties affording your hospital bill, you may qualify for medical bill relief or charity care.
What insurance does Women and Infants Hospital accept?
Women and Infants Hospital accepts a broad spectrum of insurance plans, such as Advantage EPO, Aetna APCN Open Access, Aetna Select, and more. It is advised to verify coverage with your insurance provider. The hospital provides a comprehensive range of healthcare services, including gynecologic cancer care, obstetrics and gynecology, urogynecology, laboratory services, diagnostic imaging, anesthesiology, physical therapy, pelvic health rehabilitation, emergency care, and hearing services for both children and adults.
What awards or recognition has Women and Infants Hospital received?
Women and Infants Hospital in Providence, Rhode Island, is nationally recognized for its research in newborn hearing screening, Down Syndrome detection, and diabetes in pregnancy. It serves as a major teaching affiliate of The Warren Alpert Medical School of Brown University, focusing on obstetrics, gynecology, and newborn pediatrics. The hospital's researchers are supported by grants from various agencies and foundations, including the National Institutes of Health.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.